重组人ULBP2蛋白; 重组UMPS蛋白; 重组人UNC119B蛋白; 重组大肠杆菌ung蛋白; 重组人UPK2蛋白; 重组人UPK3A蛋白; 重组人UPP1蛋白; 重组人UPRT蛋白; 重组人UQCRC1蛋白; 重组人UQCRC2蛋白; 重组人UQCRH蛋白; 重组人UQCRQ蛋白; 重组人URM1蛋白; 重组人UROD蛋白; 重组人UROS蛋白; 重组人USE1蛋白; 重组人USF1蛋白; 重组人USP14蛋白; 重组人USP15蛋白; 重组人USP46蛋白; 重组人UTP23蛋白; 重组人UXT蛋白; 重组小鼠Vamp2蛋白; 重组人VAMP4蛋白; 重组人VAMP5蛋白; 重组人VAMP7蛋白; 重组人VAMP8蛋白; 重组人VAPA蛋白; 重组人VAPB蛋白; 重组小鼠Vascular cell adhesion protein 1蛋白; 重组人Vasostatin 2蛋白; 重组人VASP蛋白; 重组人Vaspin蛋白; 重组人VAT1蛋白; 重组人VAV1蛋白; 重组人VBP1蛋白; 重组人VCAM1蛋白; 重组人VCPKMT蛋白; 重组小鼠VEGF蛋白; 重组人VEGF-B蛋白; 重组人VEGF121蛋白; 重组人VEGF165蛋白; 重组大鼠VEGFA蛋白; 重组人VEGFC蛋白; 重组人VHL protein蛋白; 重组小鼠Visfatin蛋白; 重组人Visfatin蛋白; 重组人Visinin-like protein-1蛋白; 重组人VOPP1蛋白; 重组人VPS24蛋白; 重组人VPS25蛋白; 重组人VPS26A蛋白; 重组人VPS28蛋白; 重组人VPS29蛋白; 重组小鼠VPS29蛋白; 重组人VPS4B蛋白; 重组人VRK3蛋白; 重组人VSTM2L蛋白; 重组人VTA1蛋白; 重组人VTCN1蛋白; 重组人VTI1B蛋白; 重组人VTN蛋白; 重组人WARS蛋白; 重组人WBP2蛋白; 重组人WDR5蛋白; 重组人WFDC12蛋白; 重组人WHSC2蛋白; 重组人WIBG蛋白; 重组人Wif-1蛋白; 重组人WLS蛋白; 重组小鼠Wnt inhibitory factor 1蛋白; 重组人WNT3a蛋白; 重组人WNT7A蛋白; 重组WRS (Tryptophanyl-tRNA synthetase)蛋白; 重组人WWC1蛋白; 重组人WWOX蛋白; 重组人WWTR1蛋白; 重组人XAB1蛋白; 重组人XAF1蛋白; 重组人XAGE1A蛋白; 重组人XG蛋白; 重组人XPA蛋白; 重组人XPNPEP1蛋白; 重组人XRCC2蛋白; 重组人XRCC3蛋白; 重组人YAE1D1蛋白; 重组人YARS蛋白; 重组人YARS2蛋白; 重组人YBX1蛋白; 重组人YEATS4蛋白; 重组人YIF1B蛋白; 重组人YOD1蛋白; 重组YRS (Tyrosyl-tRNA synthetase)蛋白; 重组人YWHAB蛋白; 重组人YWHAE蛋白; 重组人YY1蛋白; 重组人ZADH2蛋白; 重组人ZC4H2蛋白; 重组人ZCCHC12蛋白; 重组人ZCCHC17蛋白; 重组人ZFAND1蛋白; 重组人ZFAND3蛋白; 重组人ZFAND5蛋白; 重组人ZG16蛋白; 重组人Zinc-alpha-2-glycoprotein蛋白; 重组人ZMAT3蛋白; 重组人ZNF32蛋白; 重组人ZNF346蛋白; 重组人ZNF514蛋白; 重组人ZNF689蛋白; 重组人ZNHIT1蛋白; 重组人ZNHIT3蛋白; 重组人ZNRD1蛋白; 重组人ZWILCH蛋白; 重组ZWINT蛋白; 重组人ApoE蛋白; 重组人GABA蛋白; 重组人SUMO2蛋白; 重组人SMT3A蛋白; 重组人NEDD8蛋白; 重组人Somatoliberin蛋白; 重组小鼠EFNA1蛋白; 重组小鼠EFNB2蛋白; 重组人UBC5A蛋白; 重组人Leptin蛋白; 重组小鼠Inducible T-cell Costimulator蛋白; 重组小鼠PPIase A蛋白; 重组小鼠CTLA-4蛋白; 重组大鼠Igg-2a蛋白; 重组小鼠PG40蛋白; 重组小鼠ALK-1蛋白; 重组小鼠EFNA4蛋白; 重组小鼠EFNB1蛋白; 重组小鼠CD28蛋白; 重组人CD159a蛋白; 重组小鼠EGF蛋白; 重组人ASF1A蛋白; 重组小鼠Interferon α-2蛋白; 重组人IGF1蛋白; 重组人UBE2D4蛋白; 重组人ITM2B蛋白; 重组人CD137蛋白; 重组人Ubiquitin Carrier Protein H蛋白; 重组人IFN-γ蛋白; 重组人UBE2G2蛋白; 重组人CTLA-4蛋白; 重组人UBE2T蛋白; 重组人EFNA4蛋白; 重组人EFNB2蛋白; 重组人ATG3蛋白; 重组人CRYAA蛋白; 重组人CD276蛋白; 重组人Beta-2-Microglobulin蛋白; 重组人β-NGF(Ser122-Arg239)蛋白; 重组人Activation B7-1 Antigen蛋白; 重组人CD265蛋白; 重组小鼠DTK蛋白; 重组人SNCG蛋白; 重组人NovoNectin蛋白; 重组人SENP2蛋白; 重组人SENP8蛋白; 重组人HSA蛋白; 重组人CD357蛋白; 重组人CD166 Antigen蛋白; 重组小鼠ICAM-2蛋白; 重组人CD28蛋白; 重组人Small Ubiquitin-Related Modifier 3蛋白; 重组人N2DL2蛋白; 重组人CFB蛋白; 重组人CD262蛋白; 重组人CD263蛋白; 重组人IGF-I(4-70)蛋白; 重组人ITGA5蛋白; 重组人SLAM Family Member 7蛋白; 重组人VMO1蛋白; 重组人GLB1蛋白; 重组人LTBR蛋白; 重组人Glial Cell line-derived Neurotrophic Factor Receptor alpha 2蛋白; 重组人Death Receptor 6蛋白; 重组人CD27蛋白; 重组人TNF-alpha蛋白; 重组人Thioredoxin蛋白; 重组人CD253蛋白; 重组人IL-1R7蛋白; 重组人CALC2蛋白; 重组人FKBP4蛋白; 重组人Ubiquitin Carrier Protein 9蛋白; 重组人TNFα蛋白; 重组人IL18BP蛋白; 重组人Interleukin-25蛋白; 重组人Profilin-2蛋白; 重组人Interleukin-21 Receptor蛋白; NKG2D ligand 2; N2DL2; RAET1H; ULBP2; ALCAN-alpha; NKG2DL2; Uridine 5'-monophosphate synthase; OPRT; Protein unc-119 homolog B; POC7B; Uracil-DNA-glycosylase; ECK2578; JW2564; Uroplakin-2; UP2; UPII; Uroplakin-3a; UPK3; Uridine phosphorylase 1; UP; UPASE; UPP; UrdPase 1; Uracil phosphoribosyltransferase homolog; Uracil phosphoribosyltransferase (FUR1) homolog (S.cerevisiae); FUR1; RP11-311P8.3; ubiquinol-cytochrome c reductase core protein I; D3S3191; QCR1; UQCR1; Cytochrome b-c1 complex subunit 2; mitochondrial; QCR2; UQCR2; ubiquinol-cytochrome c reductase hinge protein; QCR6; UQCR8; Cytochrome b-c1 complex subunit 8; Ubiquinol-cytochrome c reductase; complex III subunit VII; 9.5kDa; QCR8; QP-C; QPC; UQCR7; Ubiquitin-related modifier 1 homolog; C9orf74; MGC2668; RP11-339B21.4; PCT; Uroporphyrinogen decarboxylase; UPD; URO D; URO-D; Uroporphyrinogen-III synthase; Uroporphyrinogen III synthase; Vesicle transport protein USE1; MDS032; P31; SLT1; Upstream transcription factor 1; bHLHb11; FCHL; FCHL1; HYPLIP1; MLTF; MLTFI; UEF; Ubiquitin carboxyl-terminal hydrolase 14; TGT; Ubiquitin thioesterase 14; Ubiquitin carboxyl-terminal hydrolase 15 isoform 3; UNPH-2; UNPH4; ubiquitin carboxyl-terminal hydrolase 46 isoform 1; Deubiquitinating enzyme 46; FLJ12552; Ubiquitin carboxyl-terminal hydrolase 46; Ubiquitin thioesterase 46; Ubiquitin-specific-processing protease 46; rRNA-processing protein UTP23 homolog; C8orf53; Protein UXT; ART-27; STAP1; Vesicle-associated membrane protein 2; Syb-2; Syb2; sybII; VAMP24; Vesicle-associated membrane protein 4 VAMP 24; VAMP 4; VAMP4 protein; Vesicle associated membrane protein 4; isoform CRA a; isoform CRA b; Vesicle-associated membrane protein 5; Myobrevin; Vesicle-associated membrane protein 5 Camp; VAMP 5; Vesicle associated membrane protein 5; Vesicle-associated membrane protein 7; SYBL1; TI-VAMP; TIVAMP; VAMP-7; Endobrevin; EDB; VAMP8; Vesicle-associated membrane protein 8; Vesicle-associated membrane protein 8 VAMP 5; VAMP 8; VAMP-8; VAMP5; Vesicle associated membrane protein 8; hVAP-33; VAP-33; VAP-A; VAP33; Vesicle-associated membrane protein-associated protein A VAMP A; VAMP associated protein A; VAP 33; VAP A; Vesicle associated membrane protein associated protein A; Vesicle-associated membrane protein-associated protein B/C; ALS8; VAMP-B; VAMP-C; VAP-B; VAP-C; CD106; Vcam-1; Vcam1; Chromogranin A; Vasostatin 2; beta Granin; CGA; CHG A; CHGA; ChromograninA; Chromogranin A parathyroid secretory protein 1; Chromogranin A precursor; Pancreastatin; Parastatin; Parathyroid secretory protein 1; Vasodilator-stimulated phosphoprotein; 0; SERPINA12; serpin peptidase inhibitor clade A member 12; OL-64; Visceral adipose tissue-derived serine protease inhibitor; Serpin A12 precursor; OL64 OL 64; ENSG00000165953; Synaptic vesicle membrane protein VAT-1 homolog; VATI; FLJ20230; vesicle amine transport protein 1 homolog; Proto-oncogene vav isoform 1; VAV; Proto-oncogene vav; vav 1 guanine nucleotide exchange factor; vav 1 oncogene; Prefoldin subunit 3; PFD3; PFDN3; VBP-1; Vascular cell adhesion molecule 1; DKFZp 779G2333; INCAM-100; MGC99561; Vascular cell adhesion protein 1 isoform; Protein-lysine methyltransferase METTL21D; C14orf138; METTL21D; VCP-KMT; Vegf-a; Vegf120; Vegf164; Vegf188; Vpf; Vascular endothelial growth factor A isoform 3; VEGFL; VEGF-related factor (VRF); Vascular endothelial growth factor B VEGF related factor; VRF; VEGFb; Vascular endothelial growth factor A isoform f; VEGF; Vascular endothelial growth factor A isoform f MVCD1; Vascular endothelial growth factor A; Vascular permeability factor; VEGF A; MGC70609; VEGF121; MVCD1; Vascular endothelial growth factor A isoform d; Vascular endothelial growth factor C; Flt4-L; LMPH1D; VRP; Von Hippel-Lindau tumor suppressor isoform 1; HRCA1; RCA1; VHL1; Von Hippel-Lindau tumor suppressor isoform 1 pVHL; G7 protein; Elongin binding protein; HRCA 1; RCA 1; VHL; VHL 1; VHLH; Von Hippel Lindau disease tumor suppressor; Pre-B-cell colony-enhancing factor 1; Visfatin; visfatin mouse; mouse visfatin; Nicotinamide phosphoribosyltransferase [Mus musculus]; NAMPT; MGC117256; Nicotinamide phosphoribosyltransferase precursor; PBEF; PBEF1; VF; pre-B-cell colony enhancing factor 1; VILIP; VILIP-1; VLP-1; HLP3; VSNL1; Hippocalcin like protein 3; HLP 3; HPCAL 3; HPCAL3; HUVISL1; Neurocalcin alpha; NVL 1; NVL1; Visinin.Visinin like 1; Visinin like protein 1.VISL 1; Vesicular; overexpressed in cancer; prosurvival protein 1; ECOP; GASP; Charged multivesicular body protein 3; CGI-149; CHMP3; FLJ38114; NEDF; Vacuolar protein-sorting-associated protein 25; DERP9; EAP20; FAP20; Vacuolar protein sorting-associated protein 26A; HB58; Hbeta58; PEP8A; VPS26; ESCRT-I complex subunit VPS28; H-Vps28; Vacuolar Protein Sorting 28 acuolar protein sorting 28; Vacuolar protein sorting 28 (yeast); Vacuolar protein sorting 28 homolog; Vacuolar protein sorting-associated protein; DC15; DC7; PEP11; Vacuolar protein sorting 29; Vacuolar protein sorting-associated protein 4B; MIG1; SKD1; SKD1B; VPS4-2; Inactive serine/threonine-protein kinase VRK3; Vaccinia related kinase 3; V-set and transmembrane domain containing 2 like; dJ1118M15.2; C20orf102; V set and transmembrane domain containing 2 like; vacuolar protein sorting-associated protein VTA1 homolog; DRG-1; DRG1; LIP5; SBP1; V-set domain containing T cell activation inhibitor 1; B7-H4; B7h.5; B7H4; B7S1; B7X; PRO1291; RP11-229A19.4; VCTN1; Vesicle transport through interaction with t-SNAREs homolog 1B; v-SNARE; VTI1; VTI1-LIKE; vti1-rp1; VTI1L; VTI2; Vitronectin precursor; V75; VN; VNT; GAMMA-2; IFI53; IFP53; Tryptophanyl-tRNA synthetase; cytoplasmic; TrpRS; hWRS; WW domain binding protein 2; WBP-2; BIG-3; SWD3; WD repeat-containing protein 5; BIG 3; WDR 5; WDR-5; WAP four-disulfide core domain protein 12 precursor; C20orf122; dJ211D12.4; SWAM2; WAP2; Wolf-Hirschhorn syndrome candidate 2; NELF-A; NELFA; P/OKcl.15; Negative elongation factor A; PYM; Partner of Y14 and mago; Wnt inhibitory factor 1; WIF1; Protein wntless homolog isoform 1 precursor; C1orf139; EVI; GPR177; MRP; Wif-1; AW107799; Protein Wnt-3a; wnt-3a; Protein Wnt-7a precursor; Wingless-type MMTV integration site family; member7A; Protein KIBRA isoform 3; WW and C2 domain containing 1; HBEBP3; HBEBP36; KIBRA; WW domain containing oxidoreductase; D16S432E; FOR; FRA16D; HHCMA56; PRO0128; SDR41C1; WOX1; WW domain containing oxidoreductase 5330426P09Rik; 9030416C10Rik; EC 1.1.1.- Fragile site FRA16D Oxireductase; WW domain containing transcription regulator 1; TAZ; XPA binding protein 1; GTPase; GPN1; ATPBD1A; MBDIN; NTPBP; XIAP associated factor 1 isoform 1; BIRC4BP; HSXIAPAF1; XIAPAF1; G antigen family D member 2; CT12.1; CT12.1A; CTP9; GAGED2; XAGE1; XAGE1B; XAGE1C; XAGE1D; XAGE1E; Glycoprotein Xg isoform 1 precursor; PBDX; DNA repair protein complementing XP-A cells; XP1; XPAC; Xaa-Pro aminopeptidase 1 isoform 1; APP1; SAMP; XPNPEP; XPNPEPL; XPNPEPL1; Resistin; ADSF; RSTN; XCP1; FIZZ3; RETN1; MGC126603; MGC126609; X-ray repair cross complementing protein 3; RAD51-like; Yae1 domain containing 1; C7orf361; GK003; Tyrosyl-tRNA synthetase; CMTDIC; TYRRS; YRS; YTS; mitochondrial precursor; CGI-04; FLJ13995; MLASA2; MT-TYRRS; Nuclease-sensitive element-binding protein 1; BP-8; CSDA2; CSDB; DBPB; MDR-NF1; NSEP-1; NSEP1; YB-1; YB1; YEATS domain-containing protein 4; 4930573H17Rik; B230215M10Rik; GAS41; NUBI-1; YAF9; YEATS domain containing 4; Glioma-amplified sequence 41; protein YIF1B isoform 5; FinGER8; Ubiquitin thioesterase OTU1; DUBA8; OTUD2; PRO0907; RP11-164O23.1; N/a; 14-3-3 protein beta/alpha; GW128; HEL-S-1; HS1; KCIP-1; YWHAA; 14-3-3 protein epsilon; 14-3-3E; HEL2; MDCR; MDS; YY1 transcription factor; DELTA; INO80S; NF-E1; UCRBP; YIN-YANG-1; YIN YANG 1; Zinc-binding alcohol dehydrogenase domain-containing protein 2; MGC45594; Zinc finger C4H2 domain-containing protein isoform 1; Zinc finger; C4H2 domain containing; HCA127; KIAA1166; Znc finger CCHC domain-containing protein 12; PNMA7A; SIZN; SIZN1; Nucleolar protein of 40 kDa; HSPC251; pNO40; PS1D; RP11-266K22.1; zinc finger CCHC domain containing 17; putative S1 RNA-binding domain protein; AN1-type zinc finger protein 1 isoform a; AN1-type domain; AN1-type zinc finger protein 3; AN1-type zinc finger protein 5; ZA20D2; ZFAND5A; ZNF216; zymogen granule membrane protein 16 precursor; JCLN; JCLN1; ZG16A; AZGP1; ZA2G; ZAG; Zinc finger matrin-type protein 3; PAG608; WIG-1; WIG1; Zinc finger protein 32; KOX30; Zinc finger protein 346; JAZ; Zfp346; Zinc finger protein 514; FLJ14457; MGC126229; Zinc finger protein 689; TIPUH1; Zinc finger HIT domain-containing protein 1; HIT-type containing 1; CG1I; ZNFN4A1; Zinc finger HIT domain-containing protein 3; HIT-type containing 3; TRIP3; Zinc ribbon domain containing 1; HTEX-6; hZR14; Rpa12; tctex-6; TEX6; Protein zwilch homolog; hZwilch; KNTC1AP; HZwint-1; KNTC2AP; ZWINT1; Apolipoprotein E; APOE; Apo-E; GABA(A) Receptor-Associated Protein; GABARAP Protein; HCG1987397 Isoform CRA_b; GABARAP; Small Ubiquitin-Related Modifier 2; SUMO-2; HSMT3; SMT3 homolog 2; SUMO-3; Sentrin-2; Ubiquitin-Like Protein SMT3A; Smt3A; SUMO2; SMT3H2; Small Ubiquitin-Related Modifier 3; SMT3 Homolog 1; Ubiquitin-Like Protein SMT3B; Smt3B; SUMO3; SMT3H1; Neural precursor cell expressed developmentally down-regulated protein 8; NEDD8; Neddylin; Ubiquitin-like protein Nedd8; Somatoliberin; Growth hormone-releasing factor; Somatocrinin; Somatorelin; Growth hormone-releasing hormone; GHRH; GHRF; EPH-related receptor tyrosine kinase ligand 1; Immediate early response protein B61; Epgl1; Epl1; Lerk1; Ephrin-B2; ELF-2; EPH-related receptor tyrosine kinase ligand 5; HTK ligand; Elf2; Epl5; Eplg5; Htkl; Lerk5; Ubiquitin-conjugating enzyme E2 D1; Stimulator of Fe transport; SFT; UBC4/5 homolog; UbcH5; Ubiquitin carrier protein D1; Ubiquitin-conjugating enzyme E2(17)KB 1; Ubiquitin-conjugating enzyme E2-17 kDa 1; Ubiquitin-protein ligase D1; UBC5A; UBCH5A; Leptin; Obese Protein; Obesity Factor; LEP; OB; OBS; Inducible T-cell costimulator; Activation-inducible lymphocyte immunomediatory molecule; CD28 and CTLA-4-like protein; CCLP; CD28-related protein 1; CRP-1; CD278; Icos; Ailim; Peptidyl-prolyl cis-trans isomerase A; PPIase A; Cyclophilin A; Cyclosporin A-binding protein; Rotamase A; SP18; PPIA; CYPA; Cytotoxic T-lymphocyte protein 4; Cytotoxic T-lymphocyte-associated antigen 4; CTLA-4; CD152; Ctla4; Ig gamma-2A chain C region; Igg-2a; Decorin; Bone proteoglycan II; PG-S2; PG40; Dcn; Serine/threonine-protein kinase receptor R3; SKR3; Activin receptor-like kinase 1; ALK-1; TGF-B superfamily receptor type I; TSR-I; ACVRL1; activin A receptor type II-like 1; activin A receptor; Ephrin-A4; EPH-related receptor tyrosine kinase ligand 4; Epl4; Eplg4; Lerk4; Ephrin-B1; EFL-3; ELK ligand; ELK-L; EPH-related receptor tyrosine kinase ligand 2; LERK-2; EFNB1; EFL3; EPLG2; LERK2; T-cell-specific surface glycoprotein CD28; CD28; NKG2-A/NKG2-B type II integral membrane protein; CD159 antigen-like family member A; NK cell receptor A; NKG2-A/B-activating NK receptor; CD159a; KLRC1; NKG2A; Pro-epidermal growth factor; Epidermal growth factor; EGF; Histone Chaperone ASF1A; Anti-Silencing Function Protein 1 Homolog A; hAsf1; hAsf1a; CCG1-Interacting Factor A; CIA; hCIA; ASF1A; Interferon Alpha-2; IFN-Alpha-2; Interferon Alpha-A; LeIF A; IFNA2; Insulin-Like Growth Factor I; IGF-I; Mechano Growth Factor; MGF; Somatomedin-C; IGF1; IBP1; Ubiquitin-Conjugating Enzyme E2 D4; HBUCE1; Ubiquitin Carrier Protein D4; Ubiquitin-Protein Ligase D4; UBE2D4; UBCH5D; Integral Membrane Protein 2B; Immature BRI2; imBRI2; Protein E25B; Transmembrane Protein BRI; Bri; ITM2B; BRI2; CD137; ILA; TNFRSF9; 4-1BB ligand receptor; CDw137; T-cell antigen 4-1BB homolog; T-cell antigen ILA; Ubiquitin-Conjugating Enzyme E2 H; UbcH2; Ubiquitin Carrier Protein H; Ubiquitin-Conjugating Enzyme E2-20K; Ubiquitin-Protein Ligase H; UBE2H; Interferon Gamma; IFN-Gamma; Immune Interferon; IFNG; Ubiquitin-Conjugating Enzyme E2 G2; Ubiquitin Carrier Protein G2; Ubiquitin-Protein Ligase G2; UBE2G2; UBC7; Ubiquitin-Conjugating Enzyme E2 T; Cell Proliferation-Inducing Gene 50 Protein; Ubiquitin Carrier Protein T; Ubiquitin-Protein Ligase T; UBE2T; LERK-4; EFNA4; LERK-5; HTK-L; EFNB2; Ubiquitin-like-conjugating enzyme ATG3; Autophagy-related protein 3; APG3-like; hApg3; Protein PC3-96; ATG3; APG3; APG3L; Alpha-Crystallin A Chain; Heat Shock Protein Beta-4; HspB4; Short Form; CRYAA; CRYA1; CD276; B7H34Ig-B7-H3; B7-H3; B7 homolog 3; CD276 antigen; CD276 molecule; Costimulatory molecule; Beta-2-Microglobulin; B2M; Beta-Nerve Growth Factor; Beta-NGF; NGF; NGFB; CD80; Activation B7-1 antigen; B7; BB1; CD28LG1; CD28LGB7-1 antigen; T-lymphocyte activation antigen CD80; CD265; ODFR; TNFRSF11A; TRANCE R; CD265 antigen; FEO; ODFROSTS; OFE; OPTB7; PDB2; RANK1; Receptor activator of NF-KB; receptor activator of nuclear factor-kappa B; TRANCER; tumor necrosis factor receptor superfamily member 11A; Tyrosine-protein kinase receptor TYRO3; Etk2; tyro3; TK19-2; Tyrosine-protein kinase DTK; Tyrosine-protein kinase RSE; Tyrosine-protein kinase TIF; Gamma-Synuclein; Breast Cancer-Specific Gene 1 Protein; Persyn; Synoretin; SR; SNCG; BCSG1; PRSN; NovoNectin; Fibronectin; FN; Cold-insoluble globulin; CIG; Fibronectin 1; Sentrin-specific protease 2; Axam2; SMT3-specific isopeptidase 2; Sentrin/SUMO-specific protease SENP2; KIAA1331; SENP2; Sentrin-Specific Protease 8; Deneddylase-1; NEDD8-Specific Protease 1; Protease Cysteine 2; Sentrin/SUMO-Specific Protease SENP8; SENP8; DEN1; NEDP1; PRSC2; Serum Albumin; HAS; ALB; Tumor necrosis factor receptor superfamily member 18; TNFRSF18; Glucocorticoid-induced TNFR-related protein; CD357; AITR; GITR; CD166 antigen; Activated leukocyte cell adhesion molecule; CD166; ALCAM; MEMD; Intercellular adhesion molecule 2; Icam2; ICAM-2; Lymphocyte function-associated AG-1 counter-receptor; CD102; CD102 antigen; CD28 antigen; CD28 molecule; Tp44; N2DL-2; Retinoic Acid Early Transcript 1H; UL16-Binding Protein 2; Complement Factor B; C3/C5 Convertase; Glycine-Rich Beta Glycoprotein; GBG; PBF2; Properdin Factor B; CFB; BF; BFD; Tumor Necrosis Factor Receptor Superfamily Member 10B; Death Receptor 5; TNF-Related Apoptosis-Inducing Ligand Receptor 2; TRAIL Receptor 2; TRAIL-R2; CD262; TNFRSF10B; DR5; KILLER; TRAILR2; TRICK2; ZTNFR9; Tumor Necrosis Factor Receptor Superfamily Member 10C; Antagonist Decoy Receptor for TRAIL/Apo-2L; Decoy TRAIL Receptor Without Death Domain; Decoy Receptor 1; DcR1; Lymphocyte Inhibitor of TRAIL; TNF-Related Apoptosis-Inducing Ligand Receptor 3; TRAIL Re; Integrin Alpha-5; CD49 Antigen-Like Family Member E; Fibronectin Receptor Subunit Alpha; Integrin Alpha-F; VLA-5; CD49e; ITGA5; FNRA; SLAM Family Member 7; CD2 Subset 1; CD2-Like Receptor-Activating Cytotoxic Cells; CRACC; Membrane Protein FOAP-12; Novel Ly9; Protein 19A; CD319; SLAMF7; CS1; Vitelline Membrane Outer Layer Protein 1 Homolog; VMO1; Beta-Galactosidase; Acid Beta-Galactosidase; Lactase; Elastin Receptor 1; GLB1; ELNR1; Tumor Necrosis Factor Receptor Superfamily Member 3; Lymphotoxin-Beta Receptor; Tumor Necrosis Factor C Receptor; Tumor Necrosis Factor Receptor 2-Related Protein; Tumor Necrosis Factor Receptor Type III; TNF-RIII; TNFR-III; LTBR; D12S370; TNFCR; TNFR3; T; GDNF Family Receptor Alpha-2; GDNF Receptor Alpha-2; GDNFR-Alpha-2; GFR-Alpha-2; GDNF Receptor Beta; GDNFR-Beta; Neurturin Receptor Alpha; NRTNR-Alpha; NTNR-Alpha; RET Ligand 2; TGF-Beta-Related Neurotrophic Factor Receptor 2; GFRA2; GDNFRB; RETL2; TRNR2; Tumor Necrosis Factor Receptor Superfamily Member 21; Death Receptor 6; CD358; TNFRSF21; DR6; CD27 antigen; CD27L receptor; T-cell activation antigen CD27; Tumor necrosis factor receptor superfamily member 7; T14 and TNFRSF7; DIF; TNF-alpha; TNFA; TNFSF2; Thioredoxin; Trx; ATL-Derived Factor; ADF; Surface-Associated Sulphydryl Protein; SASP; TXN; TRDX; TRX1; Tumor Necrosis Factor Ligand Superfamily Member 10; Apo-2 Ligand; Apo-2L; TNF-Related Apoptosis-Inducing Ligand; Protein TRAIL; CD253; TNFSF10; APO2L; TRAIL; Interleukin-18 receptor accessory protein (IL18RAP); Accessory protein-like; CD218 antigen-like family member B; CDw218b; IL-1R accessory protein-like; Interleukin-1 receptor 7; Interleukin-18 receptor accessory protein-like; Interleukin-18 receptor beta￡; Calcitonin gene-related peptide 2; CALC2; Beta-type CGRP; Calcitonin gene-related peptide II; CALCB; Peptidyl-prolyl cis-trans isomerase FKBP4; 51kDa FK506-binding protein; 59kDa immunophilin; FK506-binding protein 4; FKBP59; HSP-binding immunophilin; immunophilin FKBP52; Rotamase; FKBP4; SUMO-Conjugating Enzyme UBC9; SUMO-Protein Ligase; Ubiquitin Carrier Protein 9; Ubiquitin Carrier Protein I; Ubiquitin-Conjugating Enzyme E2 I; Ubiquitin-Protein Ligase I; p18; UBE2I; UBC9; UBCE9; Tumor Necrosis Factor; Cachectin; Tumor Necrosis Factor Ligand Superfamily Member 2; TNF-a; TNF; Interleukin-18-binding protein; Tadekinig-alfa and IL18BP; UPF0556 protein C19orf10; stromal cell-derived growth factor SF20; C19orf10; Myeloid-derived growth factor; MYDGF; Profilin-II; PFN2; Profilin-2; PFL; Interleukin-21 receptor; IL-21 receptor; IL-21R; CD360